Backed by these investors, Hoppen’s mission and commitments are to provide better support for patients and caregivers, and to promote more sustainable and responsible healthcare.
Committed investors
From the outset, Hoppen has benefited from the support of investors convinced by our mission. Their commitment has enabled the group to strengthen its offering, improving patient care and supporting healthcare facilities through thoughtful digitalization.
Supporting innovation
Our investors play a key role in our ability to develop solutions tailored to our customers’ needs, always in the interests of patients. They support us in our drive to become a key player in digital healthcare services, both in France and internationally.
A forward-looking strategy
Thanks to these committed partners, Hoppen continues to grow as a leader in e-health. Our disruptive innovations enable us to continually improve the services we offer patients, with the aim of building a healthier world.
GENEO
A positive investment and support company, GENEO is made up of entrepreneurs and families. It supports small and medium-sized businesses in their long-term development projects, by making positive finance available to the real economy.
Extens
A benchmark investment fund dedicated to e-health in France, Extens invests exclusively in French and European SMEs with innovative solutions: software publishers or data platforms operating in the healthcare market.
The day after tomorrow
A family-owned company based in Switzerland, Après-Demain is the parent company of a group made up of divisions active in Life Sciences, Debiopharm™, asset diversification and philanthropy. The group invests to positively impact the life course through healthcare.
